Indeed, leukemia progression was suppressed by treating AML cells with the PARP inhibitor olaparib in combination with vitamin C. Vitamin C-mediated restoration of TET2 in leukemic stem cells induces TET-mediated DNA oxidation associated DNA damage repair pathway activation. Here, TET2 is linked to leukemia.